Pazdurcanumab: US FDA’s Top Cancer Official Weighs In On That Big Neurology Approval

OCE Director Richard Pazdur is part of the US FDA's brain trust on accelerated approval • Source: photo illustration/Alamy, FDA
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Approval Standards

More from Pathways & Standards